
Advanced Accelerator Applications SA
- Home
- Companies
- Advanced Accelerator Applications SA
- Products
- Lutathera - Injection for Intravenous ...

Lutathera - Injection for Intravenous Use Initial
LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in adults.